The traditional cancer drug development pathway is increasingly being superseded by trials that address multiple clinical questions. These are collectively termed Complex Innovative Design (CID) trials. CID trials not only assess the safety and toxicity of novel anticancer medicines but also their efficacy in biomarker-selected patients, specific cancer cohorts or in combination with other agents. They can be adapted to include new cohorts and test additional agents within a single protocol. Whilst CID trials can speed up the traditional route to drug licencing, they can be challenging to design, conduct and interpret.
Effective delivery of Complex Innovat... - Lung Conditions C...
Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement.
Written by
2greys
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
New research in China
have just been reading an article on a new drug being trialed in China for COPD Esifentrine . It...
Lung Cancer Treatment
I have just been diagnosed with stage 3 lung cancer. To be precise I have T3 N2 MO, I have been...
Coughing up round balls stickey mucus
solution to this problem.
Any one has the solution can help.
There is a bark of tree 🎄 called...
Ground glass opacity.
4mm nodule with ground glass . All I can think about is cancer. I'm waiting for the results of a...
My Bladder Cancer Update.
si no tumour growth.
I still have cancer cells because I have cancer in situ (CIS) but at moment...
Cordyceps and COPD or Magic Mushrooms and the Breathless Wonder
Ordered my nebuliser today😊
There's a moose loose about the hoose
Targeted Lung Health Check Programme
ciprofloxacin V levofloxacin
